Isomorphic Labs, the drug discovery start-up spun out of Google’s DeepMind artificial intelligence unit, has raised $600mn in its first external funding round, as investors bet on the potential for AI ...

Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital, the startup said on Monday.

Demis Hassabis, a childhood chess prodigy, said his experience with the game afforded him his first brush with AI. He was ...

Demis Hassabis, Elon Musk, and Sam Altman have all warned that artificial general intelligence (AGI) will outwit humans in ...

AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...

Gemini 2.5 Pro Experimental boosts accuracy by reasoning before responding, available in Google AI Studio and for Gemini ...

Google DeepMind CEO Demis Hassabis's AI journey had an unexpected start: his early mastery of chess. Years before Hassabis ...

Nvidia has invested in a startup founded by a former Google DeepMind senior research scientist who specialized in robotics ...

Despite Google's technically superior AI tools, they consistently fail to garner the same global attention as OpenAI and ...

Isomorphic Labs is raising money in its first-ever external funding round from Thrive Capital, a big backer of ChatGPT ...

Google is doubling down on building out its AI business in the U.K. On Monday morning in London, the CEO of Google DeepMind, ...

Alphabet’s Gemini 2.5 Pro sets new AI benchmarks, powered by DeepMind and custom TPUs. Learn why GOOG stock offers long-term ...